Hayanga Jeremiah W Awori, Lira Alena, Aboagye Jonathan K, Hayanga Heather K, D'Cunha Jonathan
Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Department of Surgical Critical Care, MedStar Washington Hospital Center, Washington, DC, USA.
Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):406-10. doi: 10.1093/icvts/ivv379. Epub 2016 Jan 13.
We sought to evaluate the effect of centre volume on survival when extracorporeal membrane oxygenation (ECMO) is used as a bridge to lung transplantation (LTx).
We performed a retrospective analysis of the United Network for Organ Sharing data on adult lung transplantations performed between 2000 and 2014. Centres were categorized based on volume of transplants into low-, medium- and high-volume centres (1-5, 6-15 and >15, respectively). Baseline characteristics were assessed and a Kaplan-Meier analysis was used to estimate survival with log-rank test. We used multivariate Cox regression analysis to estimate the risk of post-transplant 1-year mortality between centres.
A total of 342 adult recipients were bridged on ECMO. Of these recipients, 88 (25.7%) were bridged in low, 89 (26%) in medium and 165 (48.2%) in high-volume centres. Patients in medium-volume centres were more likely to be older compared with those in low-volume and high-volume centres with a median age of 56, 46 and 49 years, respectively. High-volume centres reported the highest proportion (94.6%) of bilateral lung recipients, followed by low-volume (86.4%) and medium-volume centres (77.5%). The 30-day survival for the three groups was similar but 1-year survival was higher in high-volume centres (80.8) compared with medium-volume centres (70.0%) and low-volume centres (61.9%). The risk of 1-year mortality in low-volume centres was higher compared with high-volume centres in adjusted analysis (hazard ratio 2.74, 95% confidence interval 1.61-4.68, P = 0.01).
Lowest volume centres have lowest survival and there exists a volume threshold at which better outcomes are achieved.
我们旨在评估当体外膜肺氧合(ECMO)作为肺移植(LTx)的桥梁时,中心手术量对生存率的影响。
我们对器官共享联合网络中2000年至2014年间进行的成人肺移植数据进行了回顾性分析。根据移植手术量将中心分为低、中、高手术量中心(分别为1 - 5例、6 - 15例和>15例)。评估基线特征,并使用Kaplan - Meier分析和对数秩检验来估计生存率。我们使用多变量Cox回归分析来估计各中心移植后1年死亡率的风险。
共有342名成年受者通过ECMO作为桥梁进行移植。在这些受者中,88名(25.7%)在低手术量中心进行搭桥,89名(26%)在中等手术量中心,165名(48.2%)在高手术量中心。与低手术量和高手术量中心的患者相比,中等手术量中心的患者年龄更大,中位年龄分别为56岁、46岁和49岁。高手术量中心报告的双侧肺移植受者比例最高(94.6%),其次是低手术量中心(86.4%)和中等手术量中心(77.5%)。三组的30天生存率相似,但高手术量中心的1年生存率(80.8%)高于中等手术量中心(70.0%)和低手术量中心(61.9%)。在调整分析中,低手术量中心的1年死亡风险高于高手术量中心(风险比2.74,95%置信区间1.61 - 4.68,P = 0.01)。
手术量最低的中心生存率最低,并且存在一个手术量阈值,超过该阈值可获得更好的结果。